These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 31792427)

  • 1. Evolution of the innate and adaptive immune response in women with acute Zika virus infection.
    Tonnerre P; Melgaço JG; Torres-Cornejo A; Pinto MA; Yue C; Blümel J; de Sousa PSF; de Mello VDM; Moran J; de Filippis AMB; Wolski D; Grifoni A; Sette A; Barouch DH; Hoogeveen RC; Baylis SA; Lauer GM; Lewis-Ximenez LL
    Nat Microbiol; 2020 Jan; 5(1):76-83. PubMed ID: 31792427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the Americas.
    Montoya M; Collins M; Dejnirattisai W; Katzelnick LC; Puerta-Guardo H; Jadi R; Schildhauer S; Supasa P; Vasanawathana S; Malasit P; Mongkolsapaya J; de Silva AD; Tissera H; Balmaseda A; Screaton G; de Silva AM; Harris E
    J Infect Dis; 2018 Jul; 218(4):536-545. PubMed ID: 29618091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-Reactivity and Anti-viral Function of Dengue Capsid and NS3-Specific Memory T Cells Toward Zika Virus.
    Lim MQ; Kumaran EAP; Tan HC; Lye DC; Leo YS; Ooi EE; MacAry PA; Bertoletti A; Rivino L
    Front Immunol; 2018; 9():2225. PubMed ID: 30327651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus.
    Swanstrom JA; Plante JA; Plante KS; Young EF; McGowan E; Gallichotte EN; Widman DG; Heise MT; de Silva AM; Baric RS
    mBio; 2016 Jul; 7(4):. PubMed ID: 27435464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved Immune Responses Against Zika Virus After Sequential Dengue and Zika Virus Infection in Humans.
    Delgado FG; Torres KI; Castellanos JE; Romero-Sánchez C; Simon-Lorière E; Sakuntabhai A; Roth C
    Viruses; 2018 Sep; 10(9):. PubMed ID: 30205518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus.
    Dejnirattisai W; Supasa P; Wongwiwat W; Rouvinski A; Barba-Spaeth G; Duangchinda T; Sakuntabhai A; Cao-Lormeau VM; Malasit P; Rey FA; Mongkolsapaya J; Screaton GR
    Nat Immunol; 2016 Sep; 17(9):1102-8. PubMed ID: 27339099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strong CD4 T Cell Responses to Zika Virus Antigens in a Cohort of Dengue Virus Immune Mothers of Congenital Zika Virus Syndrome Infants.
    Reynolds CJ; Watber P; Santos CNO; Ribeiro DR; Alves JC; Fonseca ABL; Bispo AJB; Porto RLS; Bokea K; de Jesus AMR; de Almeida RP; Boyton RJ; Altmann DM
    Front Immunol; 2020; 11():185. PubMed ID: 32132999
    [No Abstract]   [Full Text] [Related]  

  • 8. Perinatal analyses of Zika- and dengue virus-specific neutralizing antibodies: A microcephaly case-control study in an area of high dengue endemicity in Brazil.
    Castanha PMS; Souza WV; Braga C; Araújo TVB; Ximenes RAA; Albuquerque MFPM; Montarroyos UR; Miranda-Filho DB; Cordeiro MT; Dhalia R; Marques ETA; Rodrigues LC; Martelli CMT;
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007246. PubMed ID: 30856223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Responses to Dengue and Zika Viruses-Guidance for T Cell Vaccine Development.
    Roth C; Delgado FG; Simon-Lorière E; Sakuntabhai A
    Int J Environ Res Public Health; 2018 Feb; 15(2):. PubMed ID: 29473899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained Specific and Cross-Reactive T Cell Responses to Zika and Dengue Virus NS3 in West Africa.
    Herrera BB; Tsai WY; Chang CA; Hamel DJ; Wang WK; Lu Y; Mboup S; Kanki PJ
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ontogeny of the B- and T-cell response in a primary Zika virus infection of a dengue-naïve individual during the 2016 outbreak in Miami, FL.
    Ricciardi MJ; Magnani DM; Grifoni A; Kwon YC; Gutman MJ; Grubaugh ND; Gangavarapu K; Sharkey M; Silveira CGT; Bailey VK; Pedreño-Lopez N; Gonzalez-Nieto L; Maxwell HS; Domingues A; Martins MA; Pham J; Weiskopf D; Altman J; Kallas EG; Andersen KG; Stevenson M; Lichtenberger P; Choe H; Whitehead SS; Sette A; Watkins DI
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006000. PubMed ID: 29267278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey on neutralizing antibodies against Zika virus eighteen months post-outbreak in two southern Thailand communities.
    Densathaporn T; Sangthong R; Sakolnapa M; Surasombatpattana S; Kemapunmanus M; Masrinoul P; Yoksan S; McNeil EB; Chongsuvivatwong V
    BMC Infect Dis; 2020 Dec; 20(1):921. PubMed ID: 33272192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-existing T Cell Memory against Zika Virus.
    Schouest B; Grifoni A; Pham J; Mateus J; Sydney J; Brien JD; De Silva AD; Balmaseda A; Harris E; Sette A; Weiskopf D
    J Virol; 2021 May; 95(12):. PubMed ID: 33789994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Longevity of Memory CD4 and CD8 T Cells in a Cohort of the Mothers With a History of ZIKV Infection and Their Children.
    Badolato-Corrêa J; Carvalho FR; Paiva IA; Familiar-Macedo D; Dias HG; Pauvolid-Corrêa A; Fernandes-Santos C; Lima MDRQ; Gandini M; Silva AA; Baeta Cavalcanti SM; de Oliveira SA; de Oliveira Vianna RA; de Azeredo EL; Cardoso CAA; Grifoni A; Sette A; Weiskopf D; de-Oliveira-Pinto LM
    Front Immunol; 2021; 12():610456. PubMed ID: 33679748
    [No Abstract]   [Full Text] [Related]  

  • 15. CD4
    Rivino L; Lim MQ
    Immunology; 2017 Feb; 150(2):146-154. PubMed ID: 27763656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A relevant in vitro human model for the study of Zika virus antibody-dependent enhancement.
    Londono-Renteria B; Troupin A; Cardenas JC; Hall A; Perez OG; Cardenas L; Hartstone-Rose A; Halstead SB; Colpitts TM
    J Gen Virol; 2017 Jul; 98(7):1702-1712. PubMed ID: 28691657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in understanding the adaptive immune response to Zika virus and the effect of previous flavivirus exposure.
    Andrade DV; Harris E
    Virus Res; 2018 Aug; 254():27-33. PubMed ID: 28655548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary infection with dengue or Zika virus does not affect the severity of heterologous secondary infection in macaques.
    Breitbach ME; Newman CM; Dudley DM; Stewart LM; Aliota MT; Koenig MR; Shepherd PM; Yamamoto K; Crooks CM; Young G; Semler MR; Weiler AM; Barry GL; Heimsath H; Mohr EL; Eichkoff J; Newton W; Peterson E; Schultz-Darken N; Permar SR; Dean H; Capuano S; Osorio JE; Friedrich TC; O'Connor DH
    PLoS Pathog; 2019 Aug; 15(8):e1007766. PubMed ID: 31369649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Zika virus neutralizing antibodies in healthy adults in Vietnam during and after the Zika virus epidemic season: a longitudinal population-based survey.
    Nguyen CT; Moi ML; Le TQM; Nguyen TTT; Vu TBH; Nguyen HT; Pham TTH; Le THT; Nguyen LMH; Phu Ly MH; Ng CFS; Takemura T; Morita K; Hasebe F
    BMC Infect Dis; 2020 May; 20(1):332. PubMed ID: 32393198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice.
    Fowler AM; Tang WW; Young MP; Mamidi A; Viramontes KM; McCauley MD; Carlin AF; Schooley RT; Swanstrom J; Baric RS; Govero J; Diamond MS; Shresta S
    Cell Host Microbe; 2018 Nov; 24(5):743-750.e5. PubMed ID: 30439343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.